149 related articles for article (PubMed ID: 2559616)
1. [A clinical study of congenital adrenal hyperplasia].
Nanbu A; Kumamoto Y; Tachiki H; Itoh N; Mikuma N; Tsunekawa T; Takagi Y; Maruta H
Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
Job JC; Munck A; Chaussain JL; Canlorbe P
Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
[TBL] [Abstract][Full Text] [Related]
3. [Puberty and growth development in patients with a 21-hydroxylase defect].
Börger D; Willig RP
Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
[TBL] [Abstract][Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
5. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R; Espiner EA; Abbott GD
N Z Med J; 1995 Aug; 108(1005):311-4. PubMed ID: 7644165
[TBL] [Abstract][Full Text] [Related]
6. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
[TBL] [Abstract][Full Text] [Related]
7. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM; London DR
Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
[TBL] [Abstract][Full Text] [Related]
8. [Pseudo- and central precocious puberty due to adrenogenital syndrome].
Pouw IS; Drop SL; Ladée-Levy JV; Slijper FM
Tijdschr Kindergeneeskd; 1986 Jun; 54(3):77-83. PubMed ID: 2944246
[TBL] [Abstract][Full Text] [Related]
9. Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors.
Claahsen-van der Grinten HL; Otten BJ; Sweep FC; Hermus AR
Fertil Steril; 2007 Sep; 88(3):705.e5-8. PubMed ID: 17517401
[TBL] [Abstract][Full Text] [Related]
10. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR; Lenz AM; Root AW; Diamond FB; Bercu BB
J Pediatr Endocrinol Metab; 2012; 25(9-10):977-81. PubMed ID: 23426829
[TBL] [Abstract][Full Text] [Related]
11. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
[TBL] [Abstract][Full Text] [Related]
12. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
Sarafoglou K; Addo OY; Turcotte L; Otten N; Wickremasinghe A; Pittock S; Kyllo J; Lteif AN; Himes JH; Miller BS
J Pediatr; 2014 May; 164(5):1141-1146.e1. PubMed ID: 24560184
[TBL] [Abstract][Full Text] [Related]
13. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW; Uitterlinden P; de Jong FH
Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
[TBL] [Abstract][Full Text] [Related]
14. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE; Sizonenko PC
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[TBL] [Abstract][Full Text] [Related]
15. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
Job JC; Canlorbe P; Lambertz J; Courouble P; Rossier A
Ann Pediatr (Paris); 1970; 17(6):426-31. PubMed ID: 5421325
[No Abstract] [Full Text] [Related]
16. [Hypophyseal-adrenal regulation in congenital adrenal hyperplasia (study of plasma corticotropic activity in 24 patients)].
Binoux M; Girard F; Pham-Huu-Trung MT; Canlorbe P; Mozziconacci P
Arch Fr Pediatr; 1967 Apr; 24(4):369-97. PubMed ID: 4294851
[No Abstract] [Full Text] [Related]
17. Growth and precocious puberty.
Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
[TBL] [Abstract][Full Text] [Related]
18. [Present state of diagnosis and treatment of the adrenogenital syndrome (author's transl)].
Teller WM
Klin Padiatr; 1975 Nov; 187(6):477-83. PubMed ID: 1240549
[TBL] [Abstract][Full Text] [Related]
19. Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.
Rappaport R; Bouthreuil E; Marti-Henneberg C; Basmaciogullari A
Acta Paediatr Scand; 1973 Sep; 62(5):513-9. PubMed ID: 4754146
[No Abstract] [Full Text] [Related]
20. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W; Schmidt H; Schwarz HP
Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
